A 24-Week, Randomized, Double-Blind Study of Donepezil in Moderate to Severe Alzheimer's Disease
Neurol 57:613-620, Feldman,H.,et al, 2001
Diffusion-Weighted MR Imaging of Rim-Enhancing Brain Masses:Is Markedly Decreased Water Diffusion Specific for Brain Abscess?
AJR 177:709-712, Tung,G.A., 2001
New Variant Creutzfeldt-Jakob Disease Presenting with Loss of Taste and Smell
JNNP 71:412-413, Reuber,M.&Al-Din,A.S.N., 2001
Nonpoliovirus Poliomyelitis Simulating Guillain-Barre Syndrome
Arch Neurol 58:1460-1464, Gorson,K.C.&Ropper,A.H., 2001
Tourette's Syndrome
NEJM 345:1184-1192, Jankovic,J., 2001
Improved Accuracy of Clinical Diagnosis of Lewy Body Parkinson's Disease
Neurol 57:1497-1499, Hughes,A.J.,et al, 2001
Precipitating Factors in Pituitary Apoplexy
JNNP 71:542-545, Biousse,V.,et al, 2001
Hormone Replacement Therapy and Cognition
JAMA 285:1489-1499, LeBlanc,E.S.,et al, 2001
Spontaneous Dissection of the Carotid and Vertebral Arteries
NEJM 344:898-906, Schievink,W.I., 2001
The Diagnosis of Brain Death
NEJM 344:1215-1221, 1244, Wijdicks,E.F.M., 2001
Early Detection of Dementia: Mild Cognitive Impairment (an Evidence-based Review)
Neurol 56:1133-1142, 1131, Petersen,R.C.,et al, 2001
Spontaneous Intracerebral Hemorrhage
NEJM 344:1450-1460, Qureshi,A.I.,et al, 2001
Neurodegenerative Diseases and Prions
NEJM 344:1516-1526,1548, Prusiner,S.B., 2001
Practice Parameter: Diagnosis of Dementia (an Evidence-Based Review)
Neurol 56:1143-1153, Knopman,D.S.,et al, 2001
A Reevaluation of the Duration of Survival After the Onset of Dementia
NEJM 344:1111-1116, Wolfson,C.,et al, 2001
Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease
BMJ 322:841-844, Brown,P., 2001
Primary Lymphoma of the Central Nervous System: Typical and Atypical CT and MR Imaging Appearances
AJR 176:1319-1326, Erdag,N.,et al, 2001
Amyotrophic Lateral Sclerosis
NEJM 344:1688-1700, Rowland,L.P. & Shneider,N.A., 2001
Sensory Guillain-Barre Syndrome
Neurol 56:82-86, Oh,S.J.,et al, 2001
Pathological Correlates of Late-Onset Dementia in a Multicentre, Community-based Population in England and Wales
Lancet 357:169-175, Neuroapthology Group of the Medical Research Counc, 2001
Effect of Donepezil on Brain Acetylcholineserase Activity in Patients with AD Measured by PET
Neurol 56:408-410, Shinotoh,H.,et al, 2001
Clinical Diagnosis of Cerebral Amyloid Angiopathy: Validation of the Boston Criteria
Neurol 56:537-539, Knudsen,K.A.,et al, 2001
The Interrelations of Migraine, Vertigo, and Migrainous Vertigo
Neurol 56:436-441,428, Neuhauser,H.,et al, 2001
Clinical Spectrum of Chronic Acquired Demyelinating Polyneuropathies
Muscle & Nerve 24:311-324, Saperstein,D.S.,et al, 2001
CT and MR Imaging Features of Pyogenic Ventriculitis
AJNR 22:1510-1516, Fukui, M.,et al, 2001
Bilateral Abducens Nerve Paresis Associated with Anti-GQ1b IgG Antibody
Am J Ophthalmol 131:816-818, Sato, K. and Yoshikawa, H., 2001
Acute Disseminated Encephalomyelitis
Neurol 56:1313-1318,1257, Schwarz,S.,et al, 2001
Clinical and Neuroradiologic Features of Acute Disseminated Encephalomyelitis in Children
Neurol 56:1308-1312,1257, Hynson,J.L.,et al, 2001
A 5-Month, Randomized, Placebo-controlled Trial of Galantamine in AD
Neurol 54:2269-2276, Tariot,P.N.,et al, 2000
Galantamine in AD
Neurol 54:2261-2268, Raskind,M.A.,et al, 2000
SPECT Thallium-201 Combined with Toxoplasma Serology for the Presumptive Diagnosis of Focal Central Nervous System Mass Lesions in Patients with AIDS
J Inf 40:274-281, Skiest, D.J.,et al, 2000
Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis
AJNR 21:702-706, Tintore,M.,et al, 2000
Avoiding Pitfalls in the Diagnosis of Subarachnoid Hemorrhage
NEJM 342:29-36, Edlow,J.A.&Caplan,L.R., 2000
Identifying Stroke in the Field, Prospective Validation of the Los Angeles Prehospital Stroke Screen (LAPSS)
Stroke 31:71-76, Kidwell,C.S.,et al, 2000
Donepezil Therapy in Clinical Practice, A Randomized Crossover Study
Arch Neurol 57:94-99, Greenberg,S.M.,et al, 2000
Clinical Criteria for the Diagnosis of Vascular Dementia, A Multicenter Study of Comparability and Interrater Reliability
Arch Neurol 57:191-196, Chui,H.C.,et al, 2000
Might Olfactory Dysfunction be a Marker of Early Alzheimer's Disease?
Lancet 355:84-85, Burns,A., 2000
Estrogen for Alzheimer's Disease in Women, Randomized, Double-Blind, Placebo-Controlled Trial
Neurol 54:295-301, Henderson,V.W.,et al, 2000
Amyotrophic lateral Sclerosis Mimic Syndromes, A Population-Based Study
Arch Neurol 57:109-113, Traynor,B.J.,et al, 2000
Diagnosis and Treatment of Intravascular Lymphomatosis
ArchNeurol 57:374-377, Baumann,T.P.,et al, 2000
Language Disturbances in Corticobasal Degeneration
Neurol 54:990-992, Frattali,C.M.,et al, 2000
An 80-Year-Old Man With Memory Loss
JAMA 283:1046-1053, Larson,E.B., 2000
Using Serial Registered Brain Magnetic Resonance Imaging to Measure Disease Progression in Alzheimer Disease
ArchNeurol 57:339-344, Fox,N.C.,et al, 2000
Anti-Inflammatory Drugs Protect Against Alzheimer Disease at Low Doses
Arch Neurol 57:1586-1591, Broe,G.A.,et al, 2000
Treatment of Agitation in AD
Neurol 55:1271-1278,1247, Teri,L.,et al, 2000
Dementia with Lewy Bodies in a Neuropathologic Series of Suspected Creutzfeldt-Jakob Disease
Neurol 55:1401-1404, Haik,S.,et al, 2000
Computerized Posturography Analysis of Progressive Suprnuclear Palsy
Arch Neurol 57:1464-1469, Ondo,W.,et al, 2000
Variant Creutzfeldt-Jakob Disease in UK children: A National Surveillance Study
Lancet 356: 1224-1227, Verity,C.M.,et al, 2000
AIDS-Related Focal Brain Lesions in the Era of Highly Active Antiretroviral Therapy
Neurol 55:1194-1200, Ammassari,A.,et al, 2000
Vasovagal Syncope
Ann Int Med 133:714-725, Fenton,A.M.,et al, 2000